Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy
Conclusions: This study suggests that the combination of dupilumab with a conventional drug or phototherapy may represent a valid therapeutic choice, maintaining a good safety profile in AD patients recalcitrant to dupilumab monotherapy.Dermatology
Source: Dermatology - Category: Dermatology Source Type: research
More News: Clinical Trials | Corticosteroid Therapy | Dermatitis | Dermatology | Methotrexate | Methylprednisolone | Restasis | Skin | Study